Effects of mifepristone (RU486) treatment on the development of uterine adenomyosis induced by pituitary grafting in mice

Zhou YF, Ying-Fang Zhou, Y F Zhou, Manabu Matsuda, Matsuda M, M Matsuda, Mori T, T Mori, Takao Mori, Shinobu Sakamoto, S. Sakamoto, Sakamoto S, T Mitamura, Mitamura T
Life sciences · 2000 · vol. 67(22) , pp. 2713–2720 · doi:10.1016/s0024-3205(00)00850-x · PMID:11105987 · W2081314069
Lab / animal OA: closed CC0 ⤵ 17 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This study investigated the effects of mifepristone treatment on uterine adenomyosis that developed in mice after pituitary grafting.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

To evaluate the effects of mifepristone (RU486) on the development of uterine adenomyosis induced by pituitary grafting (PG), 3 groups of mice receiving pituitary grafts at 7 weeks of age were given RU486 in food (20 mg/kg chow) from 3-14 (RU486-3 group) or 10-14 (RU486-10 group) weeks of age, or were given no further treatment (PG control group), respectively. All the mice were killed at 14 weeks of age. The uterine weight was significantly decreased in both RU486-treated groups compared with the PG control group. The incidence of adenomyosis was also decreased significantly in both the RU486-3 group (0/10 mice) and RU486-10 group (2/10 mice) compared with the PG control group (7/9 mice). To look for vascular changes in the uterine tissues, which have been reported to be related to the development of adenomyosis, immunohistochemical staining of von Willebrand factor in the blood vessels was performed. The mean surface area and minor axis of blood vessels in the uterus were thereby found to be significantly decreased in the RU486-10 group compared to the PG control group. The results clearly indicated that RU486, a potent antiprogestin, could inhibit the genesis of uterine adenomyosis in mice, and at the same time caused shrinkage of the vascular system. As in humans, progesterone as well as the vascular system therefore appear to be important factors in the pathogenesis of uterine adenomyosis in this mouse model.

My notes (saved in your browser only)

Condition tags

adenomyosis

MeSH descriptors

Adenomyoma Mifepristone Pituitary Gland Uterine Neoplasms Uterus Adenomyoma Adenomyoma Adenomyoma Animals Animals Anticarcinogenic Agents Anticarcinogenic Agents Endometrium Endometrium Endometrium Endometrium Endometrium Female Female Mice

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

Cited by (16)

Source provenance

europepmc
last seen: 2026-10-15T06:08:49.021275+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T20:59:38.477535+00:00
License: CC0 · commercial use OK